CPP Investments — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Seaport Therapeutics develops therapeutics and medicines.
BiotechMental HealthBoston, US
Daphne Zohar(Founder, CEO & Board Member)inSteven Paul, M.D.(Founder, Board Chair)inMichael Chen, Ph.D.(Co-Founder, Chief Scientific Officer)Michael Chen(Executive Officer)inLana Gladstein(Executive Officer)inAntony Loebel(Executive Officer)in
Co-investorsARCH Venture PartnersForesite CapitalGeneral AtlanticHAWKTAILPureTech HealthSofinnova Ventures+4 more
Hometree provides energy services and solutions to help homeowners and landlords decarbonise their residential properties in the UK.
CleantechEnergyInsurTechPropTechUK, GB
Simon Phelan(Founder)inSimon Phelan in(Founder)
Co-investorsAENUDN CapitalEnergy Impact PartnersFJ LabsLocalGlobeAnthemis Venture+7 more
Inari applies artificial intelligence and gene editing to accelerate plant breeding, delivering crop improvement solutions for farmers focused on soybeans, corn, and wheat across broadacre agriculture.
AgTechAI & Machine LearningBiotechCambridge, US
Lisa Safarian(CEO)inStuart Brown(Chief Financial Officer)Pierre-Etienne Boin(Secretary and General Counsel)inPonsi Trivisvavet(President and Chief Executive Officer)inDavid Berry(Founder)
BoardRobert Berendes, Ph.D.(Director)
Co-investorsFlagship PioneeringAcre Venture PartnersCongruent VenturesG Squared
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.












.jpeg)











